Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 20, 2021

SELL
$71.83 - $95.48 $81,958 - $108,942
-1,141 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$67.0 - $84.39 $76,447 - $96,288
1,141 New
1,141 $83,000
Q3 2020

Oct 15, 2020

SELL
$55.23 - $79.93 $238,483 - $345,137
-4,318 Closed
0 $0
Q2 2020

Jul 14, 2020

BUY
$30.2 - $56.98 $130,403 - $246,039
4,318 New
4,318 $240,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Fortem Financial Group, LLC Portfolio

Follow Fortem Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.